STOP Nitazenes Act
The source supplies the latest action, but no lifecycle stage.
Latest action (21 Jul 2026): Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 21.
What this bill does
The STOP Nitazenes Act, H.R. 7970, would amend the Controlled Substances Act to permanently classify a group of synthetic opioids known as nitazenes as Schedule I controlled substances. This scheduling would apply to any material containing these substances, their salts, isomers, and related compounds that exhibit specific structural modifications or act on mu-opioid receptors.
This bill primarily affects the Department of Justice and individuals involved with drug trafficking and controlled substances. By permanently scheduling nitazenes, the Act aims to strengthen the government's ability to control these substances, which are often found to be significantly more potent than fentanyl.
The bill was introduced in the House of Representatives and has been ordered reported, meaning it has passed through a committee and is awaiting further action. The next step would typically involve consideration and a potential vote by the full House of Representatives.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Strengthening Tools to Outlaw Poisonous Nitazenes Act or the STOP Nitazenes Act
This bill permanently places nitazenes as a class into schedule I of the Controlled Substances Act. Nitazenes are synthetic opioids similar to fentanyl that can be as potent or more potent than fentanyl. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
Timeline
21 Jul 2026
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 21.
Common questions
- What does H.R. 7970 do?
- The STOP Nitazenes Act, H.R. 7970, would amend the Controlled Substances Act to permanently classify a group of synthetic opioids known as nitazenes as Schedule I controlled substances. This scheduling would apply to any material containing these substances, their salts, isomers, and related compounds that exhibit specific structural modifications or act on mu-opioid receptors. This bill primarily affects the Department of Justice and individuals involved with drug trafficking and controlled substances. By permanently scheduling nitazenes, the Act aims to strengthen the government's ability to control these substances, which are often found to be significantly more potent than fentanyl. The bill was introduced in the House of Representatives and has been ordered reported, meaning it has passed through a committee and is awaiting further action. The next step would typically involve consideration and a potential vote by the full House of Representatives.
- Has H.R. 7970 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 7970. Check the latest action and official source below.
- Who sponsored H.R. 7970?
- H.R. 7970 was sponsored by Rep. Latta, Robert E. [R-OH-5] (R-OH), with 10 cosponsors.
- What's the latest action on H.R. 7970?
- Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 21. (21 Jul 2026).
Related bills in Crime and Law Enforcement
Enhancing Detection of Human Trafficking Act
National Coordination Center and Commercial Cyber Capabilities Codification Act
Supporting the goals and ideals of "National Nonviolence Week" to raise awareness of youth violence in the United States.
Anthony Amoros Law Right to Know Act
More bills from Rep. Latta, Robert E. [R-OH-5]
BEDROCK Act
Collaboration on Adversarial Threats and Security Risks Act
To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.
Nuclear REFUEL (Recycling Efficient Fuels Utilizing Expedited Licensing) Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.